Neurocrine Bioscience buy Truist Financial Co.
Start price
08.01.26
/
50%
€116.75
Target price
08.01.27
€144.77
Performance (%)
27.88%
Price
17.07.26
€149.30
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ currently has a performance of 27.88%. This prediction currently runs until 08.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.771% | -3.771% |
| iShares Core DAX® | -1,11 % | 0,20 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % |
| iShares S&P 500 | -1,79 % | 0,99 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Truist Financial Corporation from $172.00 to $169.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€154.55
13.07.26
13.07.26
€175.50
13.07.27
13.07.27
-3.40%
17.07.26
17.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€127.50
07.05.26
07.05.26
€131.84
07.05.27
07.05.27
17.10%
17.07.26
17.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
38.43%
17.07.26
17.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
25.09%
17.07.26
17.07.26